Stock analysts at William Blair issued their Q1 2025 earnings per share estimates for Toast in a research note issued on Wednesday, February 19th. William Blair analyst S. Sheldon expects that the ...
Commerce Secretary Howard Lutnick singled out the industry, alleging its use of foreign-flagged vessels lets companies avoid ...
Research analysts at William Blair cut their Q1 2025 EPS estimates for Trupanion in a note issued to investors on Thursday, ...
Hosted on MSN3d
William Blair Downgrades CACI International (CACI)Fintel reports that on February 21, 2025, William Blair downgraded their outlook for CACI International (NYSE:CACI) from ...
Merck’s Keytruda may be the most talked about drug facing loss of exclusivity but it’s far from the only one, as several of ...
Non-opioid pain therapies are entering an unprecedented era, marked by the landmark FDA approval of Vertex’s Journavx and a ...
In a report released today, Andy Hsieh from William Blair maintained a Buy rating on Cardiff Oncology (CRDF – Research Report). The company’s ...
William Blair downgraded Booz Allen (BAH) to Market Perform from Outperform.Discover the Best Stocks and Maximize Your Portfolio: See what ...
Fintel reports that on February 21, 2025, William Blair downgraded their outlook for General Dynamics (WBAG:GEDY) from Outperform to Market Perform. There are 2,727 funds or institutions reporting ...
Pediatrix Medical reported Q4 revenue of $502.36 million, surpassing estimates, with adjusted EPS of $0.51. The company ...
Repligen Corp (NASDAQ:RGEN) released its fourth-quarter adjusted EPS of 44 cents on Tuesday, down from 48 cents a year ago ...
William Blair International Growth Fund earns an Average Process Pillar rating. The main driver of the rating is the fund's excellent long-term risk-adjusted performance. This can be seen in its ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback